TW200740442A - Therapeutic agent for hypertension - Google Patents

Therapeutic agent for hypertension

Info

Publication number
TW200740442A
TW200740442A TW095130284A TW95130284A TW200740442A TW 200740442 A TW200740442 A TW 200740442A TW 095130284 A TW095130284 A TW 095130284A TW 95130284 A TW95130284 A TW 95130284A TW 200740442 A TW200740442 A TW 200740442A
Authority
TW
Taiwan
Prior art keywords
therapeutic agent
hypertension
methyl
norpregna
trien
Prior art date
Application number
TW095130284A
Other languages
English (en)
Inventor
Hideo Tsuruta
Original Assignee
Taiho Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taiho Pharmaceutical Co Ltd filed Critical Taiho Pharmaceutical Co Ltd
Publication of TW200740442A publication Critical patent/TW200740442A/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Endocrinology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
TW095130284A 2005-08-29 2006-08-17 Therapeutic agent for hypertension TW200740442A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005248212 2005-08-29

Publications (1)

Publication Number Publication Date
TW200740442A true TW200740442A (en) 2007-11-01

Family

ID=37808741

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095130284A TW200740442A (en) 2005-08-29 2006-08-17 Therapeutic agent for hypertension

Country Status (12)

Country Link
US (1) US9650408B2 (zh)
EP (1) EP1921085B1 (zh)
JP (1) JP5094400B2 (zh)
KR (1) KR20080037678A (zh)
CN (1) CN101243103B (zh)
AU (1) AU2006285902B9 (zh)
BR (1) BRPI0615346A2 (zh)
CA (1) CA2620553C (zh)
NO (1) NO20080947L (zh)
RU (1) RU2415147C2 (zh)
TW (1) TW200740442A (zh)
WO (1) WO2007026651A1 (zh)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5447941A (en) * 1993-12-21 1995-09-05 Eli Lilly And Company Methods of inhibiting pulmonary hypertensive diseases with raloxifene and related benzothiophenes
US6503896B1 (en) * 1997-12-24 2003-01-07 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6054446A (en) * 1997-12-24 2000-04-25 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
US6548491B2 (en) * 1997-12-24 2003-04-15 Sri International Anti-estrogenic steroids, and associated pharmaceutical compositions and methods of use
GB9827121D0 (en) 1998-12-09 1999-02-03 Orion Corp Agent for lowering endothelin levels
WO2001026651A2 (en) 1999-10-14 2001-04-19 Endorecherche, Inc. Selective estrogen receptor modulators in the treatment or reduction of the risk of acquiring hypertension, cardiovascular diseases, and insulin resistance
GB2374412A (en) 2001-04-11 2002-10-16 Karobio Ab Hypertension treatment and assay

Also Published As

Publication number Publication date
KR20080037678A (ko) 2008-04-30
EP1921085A1 (en) 2008-05-14
CN101243103A (zh) 2008-08-13
EP1921085A4 (en) 2010-08-25
NO20080947L (no) 2008-05-16
CN101243103B (zh) 2012-04-18
EP1921085B1 (en) 2012-08-08
US9650408B2 (en) 2017-05-16
JP5094400B2 (ja) 2012-12-12
AU2006285902A1 (en) 2007-03-08
CA2620553C (en) 2013-05-07
AU2006285902B2 (en) 2012-06-14
RU2008112142A (ru) 2009-10-10
RU2415147C2 (ru) 2011-03-27
JPWO2007026651A1 (ja) 2009-03-05
US20090281071A1 (en) 2009-11-12
WO2007026651A1 (ja) 2007-03-08
CA2620553A1 (en) 2007-03-08
BRPI0615346A2 (pt) 2011-05-17
AU2006285902B9 (en) 2012-07-05

Similar Documents

Publication Publication Date Title
GEP20115213B (en) Thienopyrimidinone derivatives as melanin concentrating hormone receptor-1 antagonists
UA94833C2 (en) Substituted bicyclolactams
EP1962838A4 (en) Farnesoid X RECEPTOR AGONISTS
TW200728307A (en) Novel spirochromanone derivatives
WO2005110410A3 (en) Kinase inhibitors as therapeutic agents
TW200608973A (en) Rapamycin polymorph Ⅱ and uses thereof
MX2009003038A (es) Derivados de quinazolinona 5-sustituidos como agentes antitumorales.
WO2007117465A3 (en) Indazole compounds
TW200505902A (en) Cannabinoid receptor ligands
WO2005082925A3 (en) Novel steroid agonist for fxr
PL364625A1 (en) N-substituted nonaryl-heterocyclic nmda/nr2b antagonists
WO2007027527A3 (en) Isoindole-imide compounds and compositions comprising and methods of using the same
WO2005080352A3 (en) Quinazoline derivatives and therapeutic use thereof
WO2007148185A3 (en) Substituted 3 -amino- pyrrolidino-4 -lactams as dpp inhibitors
TW200613243A (en) Novel compounds
TW200722100A (en) A therapeutic agent for a β related disorders
WO2005087700A3 (en) Bisphenyl compounds useful as vitamin d3 receptor agonists
WO2005094810A3 (en) Novel pharmaceutical compositions
WO2006113552A3 (en) Cyanoarylamines
WO2007084728A3 (en) 2-imino-benzimidazoles
TW200633984A (en) Amide compounds and activators of thrombopoietin receptor
DK1814848T3 (da) 2,3,4-substitueret-cyclopentanoner som terapeutiske midler
WO2008008660A3 (en) Cyclopentane derivatives as antiglaucoma agents
MX2010004487A (es) Derivados lactamicos sustituidos y sus usos para glaucoma e hipertension ocular.
WO2007103762A3 (en) Compositions and methods of use of electron transport system inhibitors